Targanta Therapeutics Corp.
222 Third St.
Suite 2300
Cambridge, Massachusetts
02142
|
| |
| Phone: |
(617) 577-9020 |
Fax:
|
(617) 577-9021
|
| Email: |
 |
Click here for a map
|
- Investors:
-
Susan Hager
Vice President, Investor Relations and Corporate Communications
Targanta Therapeutics Corporation
(617) 577-9020 x217
- Accounting Firm:
-
Ernest & Young LLP
200 Clarendon Street
Boston, Massachusetts 02116
(617) 266-2000
- Stock Transfer Agent:
-
Continental Stock Transfer & Trust Company
17 Battery Place
New York, New York, 10004
(212) 509-4000
For information on ongoing clinical trials, please visit: www.clinicaltrials.gov
Additional Corporate Locations:
|
Targanta Therapeutics Corp.
225 S. East St.
Suite 390
Indianapolis, IN 46202-4002
|
| |
| Phone: |
(317) 536-7707 |
Fax:
|
(317) 536-7737
|
|
|
Click here for a map
|
Targanta Therapeutics
7170 Frederick Banting
2nd Floor
St. Laurent, QC H4S 2A1
|
| |
| Phone: |
(514) 332-1008 |
Fax:
|
(514) 332-6033
|
|
|
Click here for a map
|
Targanta Lab - (Biotech Research Institiute, NRC)
6100 Ave. Royalmount
Montreal, QC H4P 2R2
|
| |
| Phone: |
(514) 496-6667 |
|
|
|
|
Click here for a map
|
Targanta Lab - (Mispro Biotech)
2901 Rue Rachel E.
Montreal, QC H1W 4A4
|
| |
| Phone: |
(514) 523-2825 (514) 523-9591 |
|
|
|
|
Click here for a map
|